Skip to main content

Vor Biopharma

Vor Biopharma Inc is an American clinical-stage biopharmaceutical enterprise headquartered in Cambridge, Massachusetts. The company specializes in the development of engineered hematopoietic stem cell (HSC) therapies designed to improve the effectiveness and safety of cancer treatments (such as CAR-T therapies), utilizing proprietary cell-engineering technology to create treatment-resistant blood cells. Principal revenue is currently earned through research collaborations, grant funding, and capital financing arrangements as clinical pipelines advance. Vor Biopharma is publicly listed on the Nasdaq Stock Market.

4 of the funds FundTelligence covers report a position in Vor Biopharma.

Legal name
Vor Biopharma Inc
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Autoimmune diseases, Treatment, Women's Health

Funds holding Vor Biopharma

Loading...